APA (7th ed.) Citation

Navani, N., van Doornewaard, A., Schneider, V., Marson Smith, P., Shah, R., Greystoke, A., . . . Popat, S. (2024). 119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study. Lung Cancer (01695002), 190, N.PAG. https://doi.org/10.1016/j.lungcan.2024.107680

Chicago Style (17th ed.) Citation

Navani, Neal, et al. "119 Estimating the Health Benefits of Introducing CtDNA Next Generation Sequencing to the Diagnostic Pathway for Advanced Lung Cancer: A Modelling Study." Lung Cancer (01695002) 190 (2024): N.PAG. https://doi.org/10.1016/j.lungcan.2024.107680.

MLA (9th ed.) Citation

Navani, Neal, et al. "119 Estimating the Health Benefits of Introducing CtDNA Next Generation Sequencing to the Diagnostic Pathway for Advanced Lung Cancer: A Modelling Study." Lung Cancer (01695002), vol. 190, 2024, p. N.PAG, https://doi.org/10.1016/j.lungcan.2024.107680.